Literature DB >> 26820681

Combining Normobaric Oxygen with Ethanol or Hypothermia Prevents Brain Damage from Thromboembolic Stroke via PKC-Akt-NOX Modulation.

Lipeng Cai1,2,3, James Stevenson3, Xiaokun Geng2,3, Changya Peng3, Xunming Ji4,5, Ruiqiang Xin3,6, Radhika Rastogi3, Christopher Sy3, Jose A Rafols7, Yuchuan Ding8,9,10.   

Abstract

In a thromboembolic stroke model after reperfusion by recombinant tissue plasminogen activator (rt-PA), we aimed to determine whether therapeutic hypothermia (TH) and ethanol (EtOH) in combination with low concentration (60 %) of normobaric oxygen (NBO) enhanced neuroprotection, as compared to using each of these agents alone. We further aimed to elucidate a potential role of the NADPH oxidase (NOX), phosphorylated protein kinase B (Akt), and protein kinase C-δ (PKC-δ) pathway in oxidative stress and neuroprotection. In Sprague-Dawley rats, a focal middle cerebral artery (MCA) occlusion was induced by an autologous embolus in the following experimental groups: rt-PA treatment alone, rt-PA + NBO treatment, rt-PA + TH at 33 °C, rt-PA + EtOH, rt-PA + NBO + EtOH, rt-PA + NBO + TH, rt-PA + NOX inhibitor, rt-PA + EtOH + NOX inhibitor, or rt-PA + EtOH + Akt inhibitor. Control groups included sham-operated without stroke or stroke without treatment. Infarct volume and neurological deficit were assessed at 24 h after rt-PA-induced reperfusion with or without treatments. ROS levels, NOX activity, and the protein expression of NOX subunits p22phox, p47phox, p67phox, gp91phox, as well as PKC-δ and phosphorylated Akt were measured at 3 and 24 h after rt-PA-induced reperfusion. Following rt-PA in thromboembolic stroke rats, NBO combined with TH or EtOH more effectively decreased infarct volume and neurological deficit, as well as reactive oxygen species (ROS) production than with any of the used monotherapies. NOX activity and subunit expressions were downregulated and temporally associated with reduced PKC-δ and increased p-Akt expression. The present study demonstrated that combining NBO with either TH or EtOH conferred similar neuroprotection via modulation of NOX activation. The results suggest a role of Akt in NOX activation and implicate an upstream PKC-δ pathway in the Akt regulation of NOX. It is possible to substitute EtOH for TH, thus circumventing the difficulties in clinical application of TH through the comparatively easier usage of EtOH as a potential stroke management.

Entities:  

Keywords:  Akt; Autologous embolus; Ischemia/reperfusion; NOX; Neuroprotection; PKC-δ; ROS; Thrombolytic therapy

Mesh:

Substances:

Year:  2016        PMID: 26820681     DOI: 10.1007/s12035-016-9695-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  63 in total

1.  Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans.

Authors:  Stavros P Loukogeorgakis; Merlijn J van den Berg; Reecha Sofat; Dorothea Nitsch; Marietta Charakida; Bu'Hussein Haiyee; Eric de Groot; Raymond J MacAllister; Taco W Kuijpers; John E Deanfield
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 2.  The medical use of oxygen: a time for critical reappraisal.

Authors:  F Sjöberg; M Singer
Journal:  J Intern Med       Date:  2013-12       Impact factor: 8.989

3.  Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway.

Authors:  Xingshun Xu; Chu Chang Chua; Jinping Gao; Kao-Wei Chua; Hong Wang; Ronald C Hamdy; Balvin H L Chua
Journal:  Brain Res       Date:  2008-06-16       Impact factor: 3.252

Review 4.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

5.  Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-α-induced apoptosis.

Authors:  Shyamali Basuroy; Dilyara Tcheranova; Sujoy Bhattacharya; Charles W Leffler; Helena Parfenova
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

6.  Hypothermia and Ischemic Stroke.

Authors:  Rainer Kollmar; Stefan Schwab
Journal:  Curr Treat Options Neurol       Date:  2012-02-01       Impact factor: 3.598

7.  A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice.

Authors:  Ko-Eun Choi; Casey L Hall; Jin-Mei Sun; Ling Wei; Osama Mohamad; Thomas A Dix; Shan P Yu
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

8.  Apocynin improves outcome in experimental stroke with a narrow dose range.

Authors:  X N Tang; B Cairns; N Cairns; M A Yenari
Journal:  Neuroscience       Date:  2008-04-23       Impact factor: 3.590

9.  The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways.

Authors:  Xuwen Gao; Hanfeng Zhang; Tetsuya Takahashi; Jason Hsieh; Janette Liao; Gary K Steinberg; Heng Zhao
Journal:  J Neurochem       Date:  2008-01-07       Impact factor: 5.372

10.  Normobaric oxygen therapy in acute ischemic stroke: A pilot study in Indian patients.

Authors:  M V Padma; A Bhasin; R Bhatia; A Garg; M B Singh; M Tripathi; K Prasad
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

View more
  14 in total

1.  [Salidroside protects PC12 cells from H2O2-induced apoptosis via suppressing NOX2-ROS-MAPKs signaling pathway].

Authors:  Zhi-Lin Qi; Yin-Hua Liu; Shi-Mei Qi; Lie-Feng Ling; Zun-Yong Feng; Qiang Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  Icariin enhance mild hypothermia-induced neuroprotection via inhibiting the activation of NF-κB in experimental ischemic stroke.

Authors:  Mingming Dai; Bin Chen; Xiaozhi Wang; Chang Gao; Hang Yu
Journal:  Metab Brain Dis       Date:  2021-05-12       Impact factor: 3.584

3.  Normobaric oxygen therapy attenuates hyperglycolysis in ischemic stroke.

Authors:  Zhe Cheng; Feng-Wu Li; Christopher R Stone; Kenneth Elkin; Chang-Ya Peng; Redina Bardhi; Xiao-Kun Geng; Yu-Chuan Ding
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

4.  Hydrogen Sulfide Protects Against Uremic Accelerated Atherosclerosis via nPKCδ/Akt Signal Pathway.

Authors:  Xiangxue Lu; Han Li; Shixiang Wang
Journal:  Front Mol Biosci       Date:  2021-02-09

Review 5.  NOX Activation by Subunit Interaction and Underlying Mechanisms in Disease.

Authors:  Radhika Rastogi; Xiaokun Geng; Fengwu Li; Yuchuan Ding
Journal:  Front Cell Neurosci       Date:  2017-01-10       Impact factor: 5.505

Review 6.  Oxygen or cooling, to make a decision after acute ischemia stroke.

Authors:  Wen-Cao Liu; Xin-Chun Jin
Journal:  Med Gas Res       Date:  2016-12-30

7.  Phenothiazines Enhance Mild Hypothermia-induced Neuroprotection via PI3K/Akt Regulation in Experimental Stroke.

Authors:  Hong An; Yunxia Duan; Di Wu; James Yip; Omar Elmadhoun; Joshua C Wright; Wenjuan Shi; Kaiyin Liu; Xiaoduo He; Jingfei Shi; Fang Jiang; Xunming Ji; Yuchuan Ding
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

8.  NADPH oxidase 2 does not contribute to early reperfusion-associated reactive oxygen species generation following transient focal cerebral ischemia.

Authors:  Yuan Zhang; Ting Wang; Ke Yang; Ji Xu; Jian-Ming Wu; Wen-Lan Liu
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

9.  Synergistically Induced Hypothermia and Enhanced Neuroprotection by Pharmacological and Physical Approaches in Stroke.

Authors:  Jun Zhang; Kaiyin Liu; Omar Elmadhoun; Xunming Ji; Yunxia Duan; Jingfei Shi; Xiaoduo He; Xiangrong Liu; Di Wu; Ruiwen Che; Xiaokun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

Review 10.  Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence.

Authors:  Zheng Zhang; Linlei Zhang; Yuchuan Ding; Zhao Han; Xunming Ji
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.